|
Please click on any title below to view that presentation
Monday
Forum
Mr. Dirk Collier;
VP Administration and Information Management & Chairman, Johnson & Johnson Corporate Social Responsibility Committee Europe
The role of the corporate credo in the healthcare industry
Dr. Harald Deutsch;
Partner, Health & Life Sciences, Accenture
Innovation & technology: bridging outlays to savings
Dr. Andrew Dillon;
Chief Executive Officer, National Institute for Clinical Excellence
The payer perspective
Dr. Jeffrey M. Drazen, M.D.;
Editor-in-Chief, New
England Journal of Medicine; Professor of Medicine,
Harvard Medical School
Conflict of Interest, Clinical Trials, and Peer Review
Dr. Wendy Everett;
President, New England Healthcare Institute
The impact of emerging healthcare
technology: Innovation, quality & cost
Dr. Jiefu Huang;
Vice Minister, Ministry of Health, China
The healthcare reform agenda in China: 2004-2010
Prof. Jay Sanders;
President/CEO, The Global Telemedicine Group
From Mars To Main Street - The current realities in medical technology
Library
Dr. Elliot Menschik;
Chief Executive Officer, HX Technologies
Part 1
part 2
Seminar Room 3
Frederick Hrkac;
Vice President of Global Marketing & Europe, Biosense Webster, Johnson & Johnson
Which technologies are most useful for doctors and patients?
Dr. Albert Mulley;
Chief of Internal Medicine, Massachusetts General Hospital
Which technologies are most useful for doctors and patients?
Dr. David Osborn;
Director of the Vanderbilt Center for Better Health through Informatics, Vanderbilt University, United States
Which technologies are most useful for doctors and patients?
Dr. Karl-Jürgen Schmitt; Head of Communications, Siemens AG Medical
Solutions
Which technologies are most useful for doctors and patients?
AVI Part 1
AVI Part 2
Dr. Bern Shen;
Director, The Institute for the Future
Which technologies are most useful for doctors and patients?
Seminar Room 4
Mr. Nicholas Beazley;
Group Strategy and Developement Director, BUPA
Which technologies are most useful for insurers?
Mr. Robert Holland;
Chief Executive Officer, DXS Systems
Which technologies are most useful for insurers?
Dr. Daniel Schlegel;
Partner, Health & Life Sciences, Accentures
Which technologies are most useful for insurers?
Tuesday
Forum
Prof. Dr. Abdallah Daar;
Professor of Public Health
Sciences & Professor of Surgery, University of Toronto; Director, Program in
Applied Ethics and Biotechnology, University of Toronto Joint Centre for
Bioethics; Director for Ethics and Policy, McLaughlin Centre for Molecular
Medicine, University of Toronto
Biotechnology, Innovation and Global Health Equity
Dr. Jenifer Ehreth;
Director, Medtronic Europe
Problems in Least Developed Countries
Dr. Paul Ginsburg;
President, Center for Studying Health System Changen
The changing model of the pharmaceutical
industry
Dr. Chris Hentschel;
Chief Executive Officer,
Medicines for Malaria Venture
What is the role of public-private partnership
in their solution?
Dr. Michel Kazatchkine; Director, Agence nationale de recherches sur le SIDA, France
The AIDS crisis: How to balance treatment and prevention when resources are
limited
Mr. Ken Lacey;
Global Industry Managing Partner, Health & Life
Sciences, Accenture
How can the pharmaceutical industry balance
innovation, marketing and the societal demand for affordability?
Prof. Dr. Bernard Mach;
Chairman, NovImmune SA, Geneva
Innovation for drug discovery: New
paradigms in Pharma/Biotech relationships
Mr. Jaak Peeters;
Managing Director,
Janssen-Cilag Germany, Johnson & Johnson
What is the American vs. the European model?
Library
Mr. George Bennett;
Chief Executive
Officer, Health Dialogs
Advances in Disease State Management
Prof. Marius Fieschi;
Head of the Department of Medical Informatics, Hôpital Timone A, Marseille, France
War & Medicine – Whose Responsibility?
Mr. Kurt Miller;
Partner, Health & Life Sciences, Accenture
Advances in Disease State Management
Seminar Room 3
Prof. Dr. Adriano Aguzzi;
Institute for Neuropathology, University of Zurich
Who should fund basic research?
Dr. Mercy Ahun;
Principal Officer, GAVI Secretariat
How can NGOs leverage multinational companies to improve outcomes in
LDCs?
Dr. Andrew Salzman;
President and Chief Executive Officer, Inotek Pharmaceuticals
Who should fund basic research?
Dr. Jeffrey Sturchio;
VP External Affairs EMEA, Merck
How can NGOs leverage multinational companies to improve outcomes in
LDCs?
Seminar Room 4
Dr. Janet Ballantyne;
Senior
Vice President, Abt & Associates
War & Medicine – Whose Responsibility?
Aaron Schwartz;
Technology Licensing Office, Massachusetts Institute of Technology
How does a university recruit corporate partners in the bioresearch area?
Prof. Gustav K. von Schulthess;
Director of the Clinic for Nuclear Medicine, Universitätspital Zürich
How does a university recruit corporate partners in the bioresearch area?
Wednesday
Forum
Dr. Amir Attaran;
Royal Institute of International Affairs and Idealith Research Foundation
How can NGOs leverage multinational companies to improve outcomes in
LDCs?
Prof. Harry Burns;
Director of Public
Health, NHS Greater Glasgow
Chaos, complexity and population health
Dr. Catherine Hankins;
Chief Scientific Adviser and Associate Director, Strategic Information, UNAIDS
Challenges in the prevention and care of HIV/AIDS
Prof. Dr. Donald Henderson;
Center
for Biosecurity, University of Pittsburgh Medical Center
Is the current system for the management of
global epidemics effective?
Prof. Dr. Nabil Kronfol; Chairman Middle East, Global Medical Forum Foundation
Global diseases & global institutions
Mr. Robert Laszewski;
Chairman North America, Global Medical Forum Foundation
Coverage: The U.S. healthcare market at a
critical point – again
Mr. Ron Winslow;
Deputy Health and Science Editor, The Wall Street Journal
Closing Plenary
Library
Ms. Ann Haas;
Senior Officer Health Policy, AOK Bundesverband
The employers’ dilemma of rising healthcare costs
Mr. Brad Kimler;
Senior Vice President, Fidelity Investments
The employers’ dilemma of rising healthcare costs
Dr. Catharina Maulbecker;
Chairman Europe, Global Medical Library Foundation
The employers’ dilemma of rising healthcare costs
Mr. Anthony Rucci;
Executive Vice President & Chief Administrative Officer, Cardinal Health
The employers’ dilemma of rising healthcare costs
Seminar Room 3
Dr. Wendy Everett;
President, New England Healthcare Institute
How does society achieve behavior modification?
Ms. Sophia Schlette;
Project Manager, Bertelsmann Stiftung
How does society achieve behavior modification?
Dr. Derek Yach;
Special
Projects in Non-communicable Disease, World Health Organization
How does society achieve behavior modification?
Seminar Room 4
Prof. Philippe Halban;
resident, European Association for the Study of Diabetes
Who is responsible for controlling the diabetes pandemic?
Dr. Stig Pramming;
VP, Global Health Strategy, Novo
Nordisk A/SX
Who is responsible for controlling the diabetes pandemic?
|
GMF III Presentations
